semaglutide weight loss trial sign up A 72-week compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% ✓ Semaglutide: 13.7% weight loss But weight loss isn't the STEP UP Semaglutide 7.2 mg

Slow-Titration Protocol: Conservative Escalation for Nausea-Prone Users The Phase 2 trial protocol explicitly allowed prescribers to delay or skip dose escalation at physician discretion for participants who did not tolerate the protocol-specified increase (Jastreboff et al., NEJM 2023, Supplementary Appendix)

Beyond current indications, Alberta Blue Cross identifies potential future expanded uses including: Metabolic dysfunction-associated steatohepatitis (MASH) [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php] Obstructive sleep apnea (OSA) [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php] The insurer characterizes the developing GLP-1 pipeline as robust, with treatments described as more effective, broader in use, and longer between doses [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php]

At Premier MedSpa in Downers Grove, Illinois, Ridha Chakeer, MD, offers Wegovy, a once-weekly injectable that helps reduce appetite and curb cravings

What is the total cost for the entire treatment plan

TrumpRx GLP-1 Prices Land at US$350, Above Canadian List Prices TrumpRx will start GLP-1 sales at US$350 monthly dropping to US$245, while Canadian list prices for Ozempic sit near $228 and Mounjaro $300$540